Craig Mello

Type: Person
Name: Craig Mello
First reported 13 hours ago - Updated 3 hours ago - 1 reports

An international biotech tackles CRISPR gene editing tech with $25M bankroll

A hybrid international biotech upstart with deep U.S. academic roots, a company base in Basel and a plan to grow its research operations in London has landed a $25 million A round to launch another effort at gene editing using CRISPR/Cas9 technology--one ... [Published FierceBiotech - 13 hours ago]
First reported Apr 23 2014 - Updated 23 hours ago - 1 reports

'Crispr' Technology 'Edits' DNA And Corrects Adult Genes, Successfully Curing Disease

Genes are truly fascinating. They hold DNA, the very fundamental makeup of all life on Earth, and pass on instructions for how we look, act, and think from generation to generation. Genes are responsible for your eye color, your perfect pitch in music, ... [Published Medical Daily - Apr 23 2014]
First reported Apr 22 2014 - Updated Apr 23 2014 - 1 reports

RXi Pharmaceuticals Enters into Financing Facility with Lincoln Park Capital

/PRNewswire/ --RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, announced today that it has entered ... [Published FinanzNachrichten.de - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 23 2014 - 1 reports

Big Pharma pull out and share slump won’t silence RNAi advocates

RNA interference (RNAi) developers that saw stock prices fall after Novartis pulled out of the market last week have reiterated their belief in the therapeutic and revenue potential of gene silencing drugs.The discovery that artificial strands of RNA ... [Published In-Pharmatechnologist - Apr 22 2014]
First reported Apr 21 2014 - Updated Apr 22 2014 - 2 reports

?Editing? DNA to heal

STEVE CONNOR REPORTS ON THE ‘FANTASTIC ADVANCE’ OF A NEW TECHNIQUE THAT CAN ALTER LIFE-THREATENING MUTATIONS WITH PINPOINT ACCURACYA genetic disease has been cured in living adult animals for the first time using a revolutionary genome-editing technique ... [Published The Statesman - Apr 22 2014]
First reported Mar 28 2014 - Updated Mar 29 2014 - 1 reports

RXi Pharmaceuticals Reports Full Year 2013 Financial Results

WESTBOROUGH, Mass."RXi's proprietary self-delivering RNAi platform (sd-rxRNA®) provided a solid foundation for our continued product development efforts in 2013, and continues to offer potential opportunities for future value creation," said Dr. Geert ... [Published ADVFN UK - Mar 28 2014]
First reported Nov 17 2013 - Updated Nov 17 2013 - 1 reports

CRISPR

This looks like a huge development. Video . See also here , and this talk (audio) by Harvard graduate student Patrick Hsu (no relation). Independent (UK): Scientists are calling for a wider public debate on a new development in genetics that could ... [Published Information Processing - Nov 17 2013]
First reported Nov 07 2013 - Updated Nov 07 2013 - 1 reports

The Next Gene Engineering Revolution: Curing Genetic Disease and "Designer Babies" Using Crispr

Today The Independent has afascinating article on a new extremely precise gene editingtechnique called Crispr . The enzymeCAS9 derived from bacteria enables researchers to edit genomes atwill. The technique clearly has major implications for treatinggenetic ... [Published REASON Online - Nov 07 2013]

More Content

All (11) | News (9) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
CRISPR Therapeutics grabs $25 mln from Versant ... [Published PE Hub Blog - 7 hours ago]
An international biotech tackles CRISPR gene ed... [Published FierceBiotech - 13 hours ago]
CRISPR Therapeutics Raises $25 Million in Serie... [Published Business Wire - 14 hours ago]
'Crispr' Technology 'Edits' DNA And Corrects Ad... [Published Medical Daily - Apr 23 2014]
RXi Pharmaceuticals Enters into Financing Facil... [Published FinanzNachrichten.de - Apr 22 2014]
Big Pharma pull out and share slump won’t silen... [Published In-Pharmatechnologist - Apr 22 2014]
?Editing? DNA to heal [Published The Statesman - Apr 22 2014]
Revealed: Scientists ‘edit’ DNA to correct adul... [Published The Independent - Apr 21 2014]
RXi Pharmaceuticals Reports Full Year 2013 Fina... [Published ADVFN UK - Mar 28 2014]
CRISPR [Published Information Processing - Nov 17 2013]
The Next Gene Engineering Revolution: Curing Ge... [Published REASON Online - Nov 07 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
CRISPR Therapeutics grabs $25 mln from Versant ... [Published PE Hub Blog - 7 hours ago]
CRISPR Therapeutics has received $25 million in Series A funding from Versant Ventures. Based in Basel, Switzerland, CRISPR Therapeutics is a biopharmaceutical firm focused on gene-editing technology CRISPR-Cas9. PRESS RELEASE BASEL, Switzerland–(BUSINESS ...
CRISPR [Published Information Processing - Nov 17 2013]
This looks like a huge development. Video . See also here , and this talk (audio) by Harvard graduate student Patrick Hsu (no relation). Independent (UK): Scientists are calling for a wider public debate on a new development in genetics that could ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.